NCT00328367 Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia Status COMPLETED Phase PHASE4
NCT00325689 Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder. Status COMPLETED Phase PHASE4
NCT00324051 Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine Orodispersible Tablet Status COMPLETED Phase PHASE4
NCT00320723 Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia Status COMPLETED Phase PHASE4
NCT00320671 Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis Status COMPLETED Phase PHASE4
NCT00320489 Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia Status COMPLETED Phase PHASE3
NCT00316303 Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder Status COMPLETED Phase PHASE2
NCT00316238 A Study Using Rapid Acting Intramuscular Olanzapine in Agitated Patients With Schizophrenia Status COMPLETED Phase PHASE2
NCT00315081 Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine Status UNKNOWN Phase PHASE3
NCT00314613 Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal Status TERMINATED Phase PHASE4
NCT00313391 Risperdal Consta and Health Care Utilization in Patients With Schizophrenia Status COMPLETED Phase PHASE4
NCT00312962 Effectiveness of Targeted Cognitive Training for Neurological Deficits in People With Schizophrenia Status COMPLETED Phase PHASE1/PHASE2
NCT00312949 Effectiveness of an Interactive Educational Website for Improving the Quality of Mental Health Care for People With Schizophrenia Status COMPLETED Phase NA
NCT00312598 Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine Status COMPLETED Phase N/A
NCT00309413 A Clinical Trial on the Antipsychotic Properties of Cannabidiol Status COMPLETED Phase PHASE2